换一批
换一批HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.
作者：
Soo-Yon,Rhee [1]
;
Michael R,Jordan [2]
;
Elliot,Raizes [3]
;
Arlene,Chua [4]
;
Neil,Parkin [5]
;
Rami,Kantor [6]
;
Gert U,Van Zyl [7]
;
Irene,Mukui [8]
;
Mina C,Hosseinipour [9]
;
Lisa M,Frenkel [10]
;
Nicaise,Ndembi [11]
;
Raph L,Hamers [12]
;
Tobias F,Rinke de Wit [13]
;
Carole L,Wallis [14]
;
Ravindra K,Gupta [14]
;
Joseph,Fokam [15]
;
Clement,Zeh [16]
;
Jonathan M,Schapiro [17]
;
Sergio,Carmona [18]
;
David,Katzenstein [19]
;
Michele,Tang [20]
;
Avelin F,Aghokeng [21]
;
Tulio,De Oliveira [22]
;
Annemarie M J,Wensing [1]
;
Joel E,Gallant [1]
;
Mark A,Wainberg [23]
;
Douglas D,Richman [24]
;
Joseph E,Fitzgibbon [25]
;
Marco,Schito [26]
;
Silvia,Bertagnolio [27]
;
Chunfu,Yang [28]
;
Robert W,Shafer [29]
作者单位：
Department of Medicine, Stanford University, Stanford, CA, United States of America.
[1]
Tufts University School of Medicine, Boston, MA, United States of America.
[2]
Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
[3]
Medecins Sans Frontieres, Access Campaign, Geneva, Switzerland.
[4]
Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore, Singapore.
[5]
Data First Consulting, Belmont, CA, United States of America.
[6]
Alpert Medical School, Brown University, Providence, RI, United States of America.
[7]
National Health Laboratory Service, Tygerberg, Coastal Branch, South Africa.
[8]
Division of Medical Virology, Stellenbosch University, Parow, South Africa.
[9]
National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya.
[10]
UNC Project, Lilongwe, Malawi.
[11]
University of Washington and Seattle Children's Research Institute, Seattle, WA, United States of America.
[12]
Institute of Human Virology, Abuja, Nigeria.
[13]
Amsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, Netherlands.
[14]
Lancet Laboratories and BARC-SA, Johannesburg, South Africa.
[15]
Department of Infection, University College London, London, United Kingdom.
[16]
Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
[17]
Faculty of Medicine and Biomedical Sciences (FMBS) of the University of Yaounde 1, Yaounde, Cameroon.
[18]
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
[19]
National Hemophilia Center, Tel Hashomer, Israel.
[20]
Department of Haematology and Molecular Medicine, University of Witwatersrand, Johannesburg, South Africa.
[21]
National Health Laboratory Services, Johannesburg, South Africa.
[22]
Virology Laboratory CREMER-IMPM, Yaoundé, Cameroon.
[23]
Africa Centre for Health and Population Studies, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
[24]
Virology, Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
[25]
Southwest CARE Center, Santa Fe, NM, United States of America.
[26]
McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, Canada.
[27]
Department of Pathology, University of California San Diego, La Jolla, CA, United States of America.
[28]
Veterans Affairs San Diego Healthcare System, San Diego, CA, United States of America.
[29]
Drug Development and Clinical Sciences Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
[30]
HJF-DAIDS, A Division of The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.
[31]
HIV Department WHO, Geneva, Switzerland.
[32]
主题词
抗药性, 病毒(Drug Resistance, Viral);药物疗法, 联合(Drug Therapy, Combination);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);突变(Mutation);床旁诊断化验信息系统(Point-of-Care Systems);蛋白酶抑制药(Protease Inhibitors);逆转录酶抑制剂(Reverse Transcriptase Inhibitors);利托纳韦(Ritonavir);治疗失败(Treatment Failure)
DOI
10.1371/journal.pone.0145772
PMID
26717411
发布时间
2024-03-27
- 浏览16
PloS one
PloS one
e0145772页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
